HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of January 30, 2026, HUM stock price declined to $195.20 with 2,713,354 million shares trading.

HUM has a beta of 0.74, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.06 to the broad based SPY ETF.

HUM has a market cap of $23.48 billion. This is considered a Large Cap stock.

Last quarter Humana reported $33 billion in Revenue and $3.24 earnings per share. This beat revenue expectation by $650 million and exceeded earnings estimates by $.38.

In the last 3 years, HUM traded as high as $541.21 and as low as $191.39.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, IVV, VTV.

HUM has underperformed the market in the last year with a price return of -33.1% while the SPY ETF gained +15.6%. HUM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.3% and -28.6%, respectively, while the SPY returned +2.1% and 0.0%, respectively.

HUM support price is $191.20 and resistance is $202.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.